07/01/2025 9:27 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2025 2:03 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2025 7:39 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 7:33 AM | Trinity Biotech (Filer)
| Form 424B3 | |
03/30/2025 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
03/25/2025 5:29 PM | PERCEPTIVE ADVISORS LLC (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
03/21/2025 4:00 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
03/14/2025 3:30 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025 6:30 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 7:30 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 8:00 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for TRIB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
02/04/2025 7:36 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2025 4:15 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025 10:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 3:14 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 3:05 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/26/2024 5:19 PM | New Main Equity Co., Ltd. (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D | |
12/26/2024 6:12 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 8:55 PM | MiCo IVD Holdings, LLC (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/18/2024 11:02 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 3:42 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/05/2024 3:30 PM | Trinity Biotech (Filer)
| Form 424B3 | |
12/02/2024 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
11/29/2024 3:45 PM | Trinity Biotech (Filer)
| Form F-3/A | |
11/15/2024 4:00 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
11/15/2024 12:22 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 4:26 PM | PERCEPTIVE ADVISORS LLC (Filed by) Trinity Biotech (Subject)
| Form SC 13D/A | |
11/07/2024 11:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024 12:23 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024 12:24 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024 9:35 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 10:22 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 2:07 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024 5:01 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 7:11 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 4:14 PM | Trinity Biotech (Filer)
| Form 424B5 | |
09/10/2024 9:35 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 12:26 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 9:52 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 10:59 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 5:01 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
"I'm risking my reputation on this" (Ad) Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented.
And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots…
What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book. Claim your FREE copy of Crypto Revolution now. |
08/27/2024 11:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2024 3:40 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024 12:52 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 4:26 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 4:27 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 4:03 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:53 PM | Trinity Biotech (Filer)
| Form 424B5 | |
07/11/2024 5:55 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |